# Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA)

> **NCT02539810** · PHASE4 · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 4 (actual)

## Conditions studied

- Hypertension
- Hypertension Resistant to Conventional Therapy
- Angiographically Proven Grade III Unilateral or Bilateral Atherosclerotic Renal Artery Stenosis (ARAS) Greater Than or Equal to 60 Percent

## Interventions

- **DEVICE:** Renal artery Angioplasty plus stenting.
- **DRUG:** Anti hypertensive, statin and antiplatelet medication.

## Key facts

- **NCT ID:** NCT02539810
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09
- **Primary completion:** 2016-12
- **Final completion:** 2017-07
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2018-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02539810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02539810, "Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02539810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*